Latest Mri Interventions (MRIC) Headlines
MRI Interventions Secures Commitments for $3,550,000 in Private Notes Offering
GlobeNewswire - Mon Mar 10, 7:10AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) announced today that it has entered into a purchase agreement with certain accredited investors for a private placement of securities. Upon a closing under the purchase agreement, which is subject to satisfaction of certain closing conditions, MRI Interventions will receive gross proceeds of $3,550,000, before offering-related expenses. The securities being sold by the company consist of 12% second-priority secured non-convertible promissory notes due 2019 and warrants to purchase 0.3 share of MRI Interventions' common stock for each dollar in principal amount of notes sold by the company, such warrants having an exercise price of $1.75 per share.
MRI Interventions Welcomes Medical Device Operational Specialist Timothy T. Richards to Board of Directors
GlobeNewswire - Mon Mar 10, 7:05AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its Board of Directors has elected medical device executive Timothy T. Richards to the Board. Mr. Richards' diverse background in the medical technology industry includes over 25 years of international experience spanning the areas of operations, market and product development, and global commercial expansion.
MRI Interventions Announces Quarterly Product Revenues in Excess of $1 Million for the First Time for the Fourth Quarter of 2013
GlobeNewswire - Mon Mar 10, 7:00AM CDT
Full Year Product Revenues Exceed Guidance
MRI Interventions' ClearTrace System to be Featured in Presentation at the 2014 Western Atrial Fibrillation Symposium
GlobeNewswire - Thu Feb 27, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) announced today that its novel ClearTrace system for MRI-guided, catheter-based cardiac procedures will be featured in a presentation at the 7 Annual Western Atrial Fibrillation (AF) Symposium on Feb. 28-March 1 in Park City, Utah. The Western AF Symposium assembles a distinguished faculty of physicians and researchers from five continents to discuss the disorder, its relationship to heart failure, standards for patient care and technical advancements in the field.
MRI Interventions and Siemens Enter Into Agreement to Commercialize Next Generation Software Platform to Enable MRI-Guided, Catheter-Based Procedures
GlobeNewswire - Mon Feb 24, 7:08AM CST
MRI Interventions, Inc. (OTCQB:MRIC) and Siemens Healthcare announced today an agreement to co-develop and commercialize a next generation software platform that will enable minimally invasive catheter-based procedures to be performed under real-time magnetic resonance imaging (MRI) guidance. Today, virtually all catheter-based interventions are performed using fluoroscopy, an X-ray based imaging technique. The software platform, to be used in combination with companion MRI-guided catheters, will enable procedures to be performed under MRI guidance instead of fluoroscopic guidance. This shift to MRI-guided procedures is significant because MRI provides superior visualization of soft tissue, MRI provides continuous 3-D visualization, and MRI eliminates all radiation exposure for the patient and physician.
MRI Interventions to Present at Biotech Showcase 2014
GlobeNewswire - Thu Jan 09, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical technology company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today that Kimble Jenkins, MRI Interventions' Chief Executive Officer, will present at the 2014 Biotech Showcase in San Francisco, California on Wednesday, January 15, 2014. The presentation is scheduled to begin at 4:15 PM Pacific Time. A live webcast of the presentation will be available under the IR Calendar section of the MRI Interventions website. For those unable to listen to the live webcast, a replay will be available on MRI Interventions' website following the presentation.
MRI Interventions' ClearPoint System Utilized at Cincinnati Children's Hospital for Neurosurgical Shunt Placement
GlobeNewswire - Tue Jan 07, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that the first real-time MRI-guided neurosurgical shunt placement using the company's ClearPoint(R) Neuro Intervention System has been performed at Cincinnati Children's Hospital, representing the latest application of the platform system and illustrating its utility in a wide range of neurosurgical procedures.
MRI Interventions Adds Industry Veteran Maria Sainz as New Board Member
GlobeNewswire - Mon Jan 06, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its Board of Directors has elected veteran medical device executive Maria Sainz as its newest director. Ms. Sainz's distinguished career in the medical device industry spans over 20 years, and includes 10 years as the top executive for both emerging businesses and large corporate divisions, strong commercial experience bringing therapies to market, significant international experience, and service on both public and private company boards.
OTC Daily Alert Stock Watch - MRI Interventions, Inc. (OTCQB:MRIC)
WorldStockWire - Wed Dec 18, 4:45AM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
MRI Interventions' ClearPoint Neuro Intervention System Recently Profiled by Boston's ABC-TV Affiliate
GlobeNewswire - Mon Dec 16, 7:00AM CST
The ClearPoint Neuro Intervention System developed by MRI Interventions, Inc. (OTCQB:MRIC) was featured December 10 in a television segment and article reported by the ABC-TV affiliate in Boston (WCVB-TV).
Importance of Real-Time MRI Guidance in Delivery of Toca 511 Gene Therapy Directly to High Grade Glioma Presented at Annual Society for Neuro-Oncology Scientific Meeting
GlobeNewswire - Tue Dec 03, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced the presentation of clinical data demonstrating the precision of MRI-guided delivery of the investigational gene therapy Toca 511 to high grade gliomas using the company's ClearPoint Neuro Intervention System as the delivery platform. At the 4 Quadrennial Meeting of the World Federation of Neuro-Oncology, held in conjunction with the 18 Annual Society for Neuro-Oncology Scientific Meeting and Education Day, Dr. Manish Aghi, neurosurgeon at University of California, San Francisco (UCSF), presented a poster showing interim data from an ongoing Phase I clinical trial evaluating the safety and tolerability of Toca 511 in combination with Toca FC in recurrent high grade glioma patients.
MRI Interventions' ClearPoint System Facilitates Asleep DBS Surgery at San Francisco VA Medical Center for Veterans With Parkinson's Disease
GlobeNewswire - Tue Nov 19, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that Veterans Affairs Medical Center (VAMC) in San Francisco, California, has become the first VA hospital to offer MRI-guided asleep deep brain stimulation (DBS) surgery to veterans suffering from Parkinson's disease. Dr. Paul Larson, Chief of Neurosurgery at the San Francisco VAMC, led the center's first asleep DBS procedure on October 25, 2013, using the ClearPoint Neuro Intervention System's real-time MRI guidance and visualization to plan, target, and confirm results of the surgery, all within the hospital's diagnostic MRI suite.
MRI Interventions Announces Third Quarter 2013 Financial Results
GlobeNewswire - Tue Nov 12, 3:00PM CST
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today its financial results for the quarter ended September 30, 2013.
Breakthrough in Brain Surgery: Asleep DBS Can Relieve Fear and Anxiety Surrounding Surgery
PR Newswire - Tue Nov 05, 9:49AM CST
Brain surgery can be a disturbing prospect for anyone, but for patients already struggling with certain debilitating and progressive diseases like Parkinson's disease and dystonia, remaining awake throughout the procedure is an added source of fear and anxiety. A procedure called deep brain stimulation (DBS) may control life-disrupting symptoms of such movement disorders; however, during traditional "awake DBS," patients go off their medications and, although given a sedative, remain conscious during the lengthy electrode placement surgery in order to provide feedback that can help the surgeon determine the best location for the electrodes.
MRI Interventions to Present at 2013 Canaccord Genuity Medical Technology & Diagnostics Forum
GlobeNewswire - Tue Nov 05, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical technology company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today that Kimble Jenkins, MRI Interventions' Chief Executive Officer, will present at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York on Thursday, November 14, 2013. The presentation is scheduled to begin at 4:00 p.m. ET. A live webcast of the presentation will be available under the IR Calendar section of the MRI Interventions website. For those unable to listen to the live webcast, a replay will be available on MRI Interventions' website following the presentation.
MRI Interventions to Report Third Quarter 2013 Financial Results
GlobeNewswire - Tue Oct 29, 3:06PM CDT
MRI Interventions, Inc. (OTCQB:MRIC) announced today that it will release its third quarter 2013 financial results on Tuesday, November 12, 2013, after the close of the U.S. financial markets. MRI Interventions will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the company's results.
Positive Clinical and Technical Outcomes of Asleep DBS With the ClearPoint System Recently Presented
GlobeNewswire - Mon Oct 28, 7:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that outcomes data from the use of its ClearPoint Neuro Intervention System in "asleep" deep brain stimulation (DBS) surgery were presented during the 2013 Annual Meeting of the Congress of Neurological Surgeons (CNS) in San Francisco.
Clinical Outcomes, Accuracy Results of Asleep DBS With MRI Interventions' ClearPoint System to be Presented During 2013 Congress of Neurological Surgeons
GlobeNewswire - Wed Oct 16, 7:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that clinical outcomes and technical results regarding the application of its ClearPoint Neuro Intervention System in "asleep" deep brain stimulation (DBS) surgery will be presented during the 2013 Annual Meeting of the Congress of Neurological Surgeons (CNS) in San Francisco, California, October 18-23, 2013.
Brain Cancer Lesion Treated with Precisely-Aimed Laser Catheter using ClearPoint Neuro Intervention System in IMRIS iMRI
CNW Group - Tue Aug 20, 7:01AM CDT
Newest joint application of two enabling medical technologies exhibits benefits of intraoperative MRI for direct visualization when navigating to treat brain tumors and neurological disorders
MRI Interventions Secures Commitments for $3,550,000 in Private Notes Offering
GlobeNewswire - Mon Mar 10, 7:10AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) announced today that it has entered into a purchase agreement with certain accredited investors for a private placement of securities. Upon a closing under the purchase agreement, which is subject to satisfaction of certain closing conditions, MRI Interventions will receive gross proceeds of $3,550,000, before offering-related expenses. The securities being sold by the company consist of 12% second-priority secured non-convertible promissory notes due 2019 and warrants to purchase 0.3 share of MRI Interventions' common stock for each dollar in principal amount of notes sold by the company, such warrants having an exercise price of $1.75 per share.
MRI Interventions Welcomes Medical Device Operational Specialist Timothy T. Richards to Board of Directors
GlobeNewswire - Mon Mar 10, 7:05AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its Board of Directors has elected medical device executive Timothy T. Richards to the Board. Mr. Richards' diverse background in the medical technology industry includes over 25 years of international experience spanning the areas of operations, market and product development, and global commercial expansion.
MRI Interventions Announces Quarterly Product Revenues in Excess of $1 Million for the First Time for the Fourth Quarter of 2013
GlobeNewswire - Mon Mar 10, 7:00AM CDT
Full Year Product Revenues Exceed Guidance
MRI Interventions' ClearTrace System to be Featured in Presentation at the 2014 Western Atrial Fibrillation Symposium
GlobeNewswire - Thu Feb 27, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) announced today that its novel ClearTrace system for MRI-guided, catheter-based cardiac procedures will be featured in a presentation at the 7 Annual Western Atrial Fibrillation (AF) Symposium on Feb. 28-March 1 in Park City, Utah. The Western AF Symposium assembles a distinguished faculty of physicians and researchers from five continents to discuss the disorder, its relationship to heart failure, standards for patient care and technical advancements in the field.
MRI Interventions and Siemens Enter Into Agreement to Commercialize Next Generation Software Platform to Enable MRI-Guided, Catheter-Based Procedures
GlobeNewswire - Mon Feb 24, 7:08AM CST
MRI Interventions, Inc. (OTCQB:MRIC) and Siemens Healthcare announced today an agreement to co-develop and commercialize a next generation software platform that will enable minimally invasive catheter-based procedures to be performed under real-time magnetic resonance imaging (MRI) guidance. Today, virtually all catheter-based interventions are performed using fluoroscopy, an X-ray based imaging technique. The software platform, to be used in combination with companion MRI-guided catheters, will enable procedures to be performed under MRI guidance instead of fluoroscopic guidance. This shift to MRI-guided procedures is significant because MRI provides superior visualization of soft tissue, MRI provides continuous 3-D visualization, and MRI eliminates all radiation exposure for the patient and physician.
MRI Interventions to Present at Biotech Showcase 2014
GlobeNewswire - Thu Jan 09, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical technology company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today that Kimble Jenkins, MRI Interventions' Chief Executive Officer, will present at the 2014 Biotech Showcase in San Francisco, California on Wednesday, January 15, 2014. The presentation is scheduled to begin at 4:15 PM Pacific Time. A live webcast of the presentation will be available under the IR Calendar section of the MRI Interventions website. For those unable to listen to the live webcast, a replay will be available on MRI Interventions' website following the presentation.
MRI Interventions' ClearPoint System Utilized at Cincinnati Children's Hospital for Neurosurgical Shunt Placement
GlobeNewswire - Tue Jan 07, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that the first real-time MRI-guided neurosurgical shunt placement using the company's ClearPoint(R) Neuro Intervention System has been performed at Cincinnati Children's Hospital, representing the latest application of the platform system and illustrating its utility in a wide range of neurosurgical procedures.
MRI Interventions Adds Industry Veteran Maria Sainz as New Board Member
GlobeNewswire - Mon Jan 06, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its Board of Directors has elected veteran medical device executive Maria Sainz as its newest director. Ms. Sainz's distinguished career in the medical device industry spans over 20 years, and includes 10 years as the top executive for both emerging businesses and large corporate divisions, strong commercial experience bringing therapies to market, significant international experience, and service on both public and private company boards.
OTC Daily Alert Stock Watch - MRI Interventions, Inc. (OTCQB:MRIC)
WorldStockWire - Wed Dec 18, 4:45AM CST
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
MRI Interventions' ClearPoint Neuro Intervention System Recently Profiled by Boston's ABC-TV Affiliate
GlobeNewswire - Mon Dec 16, 7:00AM CST
The ClearPoint Neuro Intervention System developed by MRI Interventions, Inc. (OTCQB:MRIC) was featured December 10 in a television segment and article reported by the ABC-TV affiliate in Boston (WCVB-TV).
Importance of Real-Time MRI Guidance in Delivery of Toca 511 Gene Therapy Directly to High Grade Glioma Presented at Annual Society for Neuro-Oncology Scientific Meeting
GlobeNewswire - Tue Dec 03, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced the presentation of clinical data demonstrating the precision of MRI-guided delivery of the investigational gene therapy Toca 511 to high grade gliomas using the company's ClearPoint Neuro Intervention System as the delivery platform. At the 4 Quadrennial Meeting of the World Federation of Neuro-Oncology, held in conjunction with the 18 Annual Society for Neuro-Oncology Scientific Meeting and Education Day, Dr. Manish Aghi, neurosurgeon at University of California, San Francisco (UCSF), presented a poster showing interim data from an ongoing Phase I clinical trial evaluating the safety and tolerability of Toca 511 in combination with Toca FC in recurrent high grade glioma patients.
MRI Interventions' ClearPoint System Facilitates Asleep DBS Surgery at San Francisco VA Medical Center for Veterans With Parkinson's Disease
GlobeNewswire - Tue Nov 19, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced that Veterans Affairs Medical Center (VAMC) in San Francisco, California, has become the first VA hospital to offer MRI-guided asleep deep brain stimulation (DBS) surgery to veterans suffering from Parkinson's disease. Dr. Paul Larson, Chief of Neurosurgery at the San Francisco VAMC, led the center's first asleep DBS procedure on October 25, 2013, using the ClearPoint Neuro Intervention System's real-time MRI guidance and visualization to plan, target, and confirm results of the surgery, all within the hospital's diagnostic MRI suite.
MRI Interventions Announces Third Quarter 2013 Financial Results
GlobeNewswire - Tue Nov 12, 3:00PM CST
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today its financial results for the quarter ended September 30, 2013.
Breakthrough in Brain Surgery: Asleep DBS Can Relieve Fear and Anxiety Surrounding Surgery
PR Newswire - Tue Nov 05, 9:49AM CST
Brain surgery can be a disturbing prospect for anyone, but for patients already struggling with certain debilitating and progressive diseases like Parkinson's disease and dystonia, remaining awake throughout the procedure is an added source of fear and anxiety. A procedure called deep brain stimulation (DBS) may control life-disrupting symptoms of such movement disorders; however, during traditional "awake DBS," patients go off their medications and, although given a sedative, remain conscious during the lengthy electrode placement surgery in order to provide feedback that can help the surgeon determine the best location for the electrodes.
MRI Interventions to Present at 2013 Canaccord Genuity Medical Technology & Diagnostics Forum
GlobeNewswire - Tue Nov 05, 7:00AM CST
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical technology company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today that Kimble Jenkins, MRI Interventions' Chief Executive Officer, will present at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York on Thursday, November 14, 2013. The presentation is scheduled to begin at 4:00 p.m. ET. A live webcast of the presentation will be available under the IR Calendar section of the MRI Interventions website. For those unable to listen to the live webcast, a replay will be available on MRI Interventions' website following the presentation.
MRI Interventions to Report Third Quarter 2013 Financial Results
GlobeNewswire - Tue Oct 29, 3:06PM CDT
MRI Interventions, Inc. (OTCQB:MRIC) announced today that it will release its third quarter 2013 financial results on Tuesday, November 12, 2013, after the close of the U.S. financial markets. MRI Interventions will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the company's results.
Positive Clinical and Technical Outcomes of Asleep DBS With the ClearPoint System Recently Presented
GlobeNewswire - Mon Oct 28, 7:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that outcomes data from the use of its ClearPoint Neuro Intervention System in "asleep" deep brain stimulation (DBS) surgery were presented during the 2013 Annual Meeting of the Congress of Neurological Surgeons (CNS) in San Francisco.
Clinical Outcomes, Accuracy Results of Asleep DBS With MRI Interventions' ClearPoint System to be Presented During 2013 Congress of Neurological Surgeons
GlobeNewswire - Wed Oct 16, 7:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that clinical outcomes and technical results regarding the application of its ClearPoint Neuro Intervention System in "asleep" deep brain stimulation (DBS) surgery will be presented during the 2013 Annual Meeting of the Congress of Neurological Surgeons (CNS) in San Francisco, California, October 18-23, 2013.
Brain Cancer Lesion Treated with Precisely-Aimed Laser Catheter using ClearPoint Neuro Intervention System in IMRIS iMRI
CNW Group - Tue Aug 20, 7:01AM CDT
Newest joint application of two enabling medical technologies exhibits benefits of intraoperative MRI for direct visualization when navigating to treat brain tumors and neurological disorders
